Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00065195 · ClinicalTrials.gov registry record · Phase 2
REST: Reducing End-of-Life Symptoms With Touch
A Phase 2 study of Pain and Neoplasms, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 2
- Development phase
- 440
- Enrollment target
- 9
- Study locations
NCT00065195: Completed Phase 2 study of Pain and Neoplasms, sponsored by National Center for Complementary and Integrative Health (NCCIH).
NCT00065195 is a Phase 2 study of Pain and Neoplasms that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 440 participants, above the 303-participant average among 374 other Pain trials with a reported enrollment target (45% higher). The trial reports 9 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00065195, a Phase 2 study of Pain and Neoplasms, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 440 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of this study is to determine whether massage therapy is effective in reducing pain and distress and improving quality of life among cancer patients at life's end.
Interventions
- PROCEDURE Moving touch therapy
- PROCEDURE Nonmoving touch therapy
Study Locations (9)
Colorado
- Pike's Peak Hospice and Palliative Care - Colorado Springs
- Pathways at Hospice of Metro Denver - Denver
- University of Colorado Cancer Center - Denver
- Hospice of St. John - Lakewood
Florida
- Hope Hospice and Palliative Care - Fort Myers
- LifePath Hospice and Palliative Care, Inc. - Tampa
California
- San Diego Hospice - San Diego
Massachusetts
- Hospice Care in the Berkshires, Inc. - Pittsfield
North Carolina
- Hospice at Charlotte - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 440 participants |
| Start Date | 2003-11 |
| Est. Completion | 2007-03 |
| Phase | Phase 2 |
What the finished NCT00065195 record still lists
NCT00065195 is an interventional study that assigns participants to a tested intervention. The registered 440 participants enrollment target is mid-sized for trials with a published cap, above the 303-participant average among 374 other Pain trials with a reported enrollment target (45% higher).
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Moving touch therapy is the first listed.
NCT00065195 lists 9 locations in 5 states (Colorado, Florida, California).
Frequently Asked Questions
What is clinical trial NCT00065195 about?
NCT00065195 is a clinical study titled "REST: Reducing End-of-Life Symptoms With Touch". The purpose of this study is to determine whether massage therapy is effective in reducing pain and distress and improving quality of life among cancer patients at life's end.
What is the current status of trial NCT00065195?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 440 participants. The study started on 2003-11. Estimated completion is 2007-03.
What conditions does trial NCT00065195 study?
This clinical trial studies the following conditions: Pain, Neoplasms.
What interventions are being tested in trial NCT00065195?
The interventions under investigation include: Moving touch therapy (PROCEDURE), Nonmoving touch therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00065195?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00065195 being conducted?
This trial has 9 study locations across California, Colorado, Florida, Massachusetts, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00065195's enrollment target sits among peer trials
440 44th of 374 higher than 331 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
RECRUITING · Phase 2
-
Neural Correlates of Hypoalgesia Driven by Observation
RECRUITING · Phase 2
-
Cannabis for Palliative Care in Cancer
RECRUITING · Phase 2
-
Pain After Buffered Vs Non Buffered Articaine
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05114538 · 440 participants · NA
Improving the Part C Early Intervention Service Delivery System for Children with ASD
- NCT05117619 · 440 participants · NA
The HOME Program for Individuals With Traumatic Brain Injury and Family Members
- NCT05602194 · 440 participants · Phase 3
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
- NCT05624879 · 440 participants · NA
Accelerated Resolution Therapy for Early Maladaptive Grief
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia